Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study
By K. Kumarasamy, M. Toleman, T. Walsh, J. Bagaria, F. Butt, R. Balakrishnan, U. Chaudhary, M. Doumith, C. Giske, S. Irfan and 21 more. Lancet. Infectious Diseases (Print), 2010
2,893 citations recorded by the source corpus.
Summary Background Gram-negative Enterobacteriaceae with resistance to carbapenem conferred by New Delhi metallo-β-lactamase 1 (NDM-1) are potentially a major global health problem. We investigated the prevalence of NDM-1, in multidrug-resistant Enterobacteriaceae in India, Pakistan, and the UK. Methods Enterobacteriaceae isolates were studied from two major centres in India—Chennai (south India), Haryana (north India)—and those referred to the UK's national reference laboratory. Antibiotic susceptibilities were assessed, and the presence of the carbapenem resistance gene blaNDM-1 was established by PCR. Isolates were typed by pulsed-field gel electrophoresis of XbaI-restricted genomic DNA. Plasmids were analysed by S1 nuclease digestion and PCR typing. Case data for UK patients were reviewed for evidence of travel and recent admission to hospitals in India or Pakistan. Findings We identified 44 isolates with NDM-1 in Chennai, 26 in Haryana, 37 in the UK, and 73 in other sites in India and Pakistan. NDM-1 was mostly found among Escherichia coli (36) and Klebsiella pneumoniae (111), which were highly resistant to all antibiotics except to tigecycline and colistin. K pneumoniae isolates from Haryana were clonal but NDM-1 producers from the UK and Chennai were clonally diverse. Most isolates carried the NDM-1 gene on plasmids: those from UK and Chennai were readily transferable whereas those from Haryana were not conjugative. Many of the UK NDM-1 positive patients had travelled to India or Pakistan within the past year, or had links with these countries. Interpretation The potential of NDM-1 to be a worldwide public health problem is great, and co-ordinated international surveillance is needed. Funding European Union, Wellcome Trust, and Wyeth.
Subfields: Endocrinology, Molecular Medicine, Pharmacology
View Paper: https://www.semanticscholar.org/paper/526a9b7b8ad26898da42bae9acac31f4cde8d73a
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Endocrinology
In Molecular Medicine
In Pharmacology
Citations in the corpus
- Combating antimicrobial resistance: policy recommendations to save lives. (2011, background): “Most recently, a new antibiotic resistance mechanism (New Delhi metallo-b-lactamase 1 or NDM1) emerged in India and spread to communities in the United Kingdom [45] and the US [44].”
- The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide. (2014, background): “Spread of NDM producers has been not only extensively identified among patients from the Indian subcontinent but also from the soil [74,75].”
- Antibiotic resistance and persistence—Implications for human health and treatment perspectives (2020, positive): “However, the more frequent use of these antibiotics may increase resistance against these drugs as well, making it even more difficult to treat these infections (Kumarasamy et al , 2010).”
- A Brief History of the Antibiotic Era: Lessons Learned and Challenges for the Future (2010, background): “In his laboratory, together with chemist Alfred Bertheim and bacteriologist Sahachiro Hata, they synthesized hundreds of organoarsenic derivatives of a highly toxic drug Atoxyl and tested them in syphilis-infected rabbits.”
- Carbapenemases in Klebsiella pneumoniae and Other Enterobacteriaceae: an Evolving Crisis of Global Dimensions (2012, background): “The epicenter of their epidemic is the Indian subcontinent, where the high isolation frequency of these microorganisms in health care facilities, as well as their extensive spread in various environmental niches, has been documented repeatedly (130, 192).”
- Global Dissemination of Carbapenemase-Producing Klebsiella pneumoniae: Epidemiology, Genetic Context, Treatment Options, and Detection Methods (2016, background): “…(Arpin et al., 2012; Robert et al., 2014), Switzerland (Poirel et al., 2011g; Spyropoulou et al., 2016), Italy (Gaibani et al., 2011), the UK (Kumarasamy et al., 2010; Giske et al., 2012), Greece (Voulgari et al., 2014; Spyropoulou et al., 2016), Turkey (Poirel et al., 2014; Kilic and…”
- Antibiotic resistance and extended spectrum beta-lactamases: Types, epidemiology and treatment. (2015, background): “Investigations from India and Pakistan show an alarming and rapid increase in the prevalence of Enterobacteriaceae with NDM-1 with prevalence rate from 6.9% in a hospital in Varanasi, India, to 18.5% in Rawalpindi, Pakistan (Perry et al., 2011) and perhaps the spread of these enzyme could be even mo”
- Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance. (2011, background): “Recently, K. pneumoniae isolates with the NDM-1 (New Delhi Metallo-carbapenemase) enzyme have been identified, initially in Sweden (Yong et al., 2009) and subsequently in the United Kingdom and throughout the Indian subcontinent (Abdul Gafur, 2010; Deshpande et al., 2010; Kumarasamy et al., 2010).”
- Global Spread of Carbapenemase-producing Enterobacteriaceae (2011, background): “Plasmids carrying the blaNDM-1 gene are diverse and can harbor a high number of resistance genes associated with other carbapenemase genes (oxacillinase-48 [OXA-48] types, VIM types), plasmid-mediated cephalosporinase genes, ESBL genes, aminoglycoside resistance genes (16S RNA methylases), macrolide”
- The global epidemiology of carbapenemase-producing Enterobacteriaceae (2017, background): “45 A follow-up study showed that NDM-1-mediated carbapenem resistance was widespread in India, Pakistan, and Bangladesh.46 Since then, blaNDM-positive Enterobacteriaceae have become increasingly common in India.”